Position in AKBA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,282,008
-$2,685,865 QoQ
Shares Held
1,124,570
-60.6% QoQ
Ownership
0.406%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 53 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Derivatives in AKBA
reported options exposure · as of Mar 31, 2022CallValue
$197,450
CallShares
275,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $574,660,475 across 59 Drug Manufacturers - Specialty & Generic names. AKBA ranks #24 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
262,200 | $142,067,824 | |
| 2 | ZTS |
Zoetis Inc.
|
1,265,210 | $90,917,989 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,527,031 | $85,615,809 | |
| 4 | VTRS |
Viatris Inc
|
4,360,444 | $69,243,850 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
179,076 | $30,181,467 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
643,006 | $26,382,535 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
189,692 | $21,044,429 | |
| 8 | HLN |
Haleon plc
|
1,507,538 | $14,065,329 |
All Filings in AKBA
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,282,008 | 1,124,570 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $3,967,873 | 2,854,586 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,922,286 | 2,436,203 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,232,568 | 1,916,692 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $489,688 | 134,530 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $587,518 | 306,000 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $449,891 | 236,786 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $199,854 | 151,405 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $47,491 | 46,560 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $343,719 | 187,825 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $378,951 | 305,606 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $174,120 | 152,737 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $44 | 49 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $27 | 49 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $418 | 726 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $14,732 | 46,623 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $38,931 | 110,287 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $170,015 | 236,790 | Shares | Defined | 2022-05-12 | |
| 2022-03-31 | $197,450 | 275,000 | Call | Defined | 2022-05-12 | |
| 2021-12-31 | $1,528,180 | 676,186 | Shares | Defined | 2022-02-10 | |
| 2021-12-31 | $565,000 | 250,000 | Call | Defined | 2022-02-10 | |
| 2021-09-30 | $1,292,091 | 448,643 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $3,459,390 | 912,768 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,840,444 | 1,134,548 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $122,715 | 43,827 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $38,884 | 15,492 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $8,257,957 | 608,097 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $743,816 | 98,129 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||